These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 23228009

  • 1. Whole-brain proton MR spectroscopic imaging in Parkinson's disease.
    Levin BE, Katzen HL, Maudsley A, Post J, Myerson C, Govind V, Nahab F, Scanlon B, Mittel A.
    J Neuroimaging; 2014; 24(1):39-44. PubMed ID: 23228009
    [Abstract] [Full Text] [Related]

  • 2. Replicability of proton MR spectroscopic imaging findings in mild traumatic brain injury: Implications for clinical applications.
    Chen AM, Gerhalter T, Dehkharghani S, Peralta R, Gajdošík M, Gajdošík M, Tordjman M, Zabludovsky J, Sheriff S, Ahn S, Babb JS, Bushnik T, Zarate A, Silver JM, Im BS, Wall SP, Madelin G, Kirov II.
    Neuroimage Clin; 2023; 37():103325. PubMed ID: 36724732
    [Abstract] [Full Text] [Related]

  • 3. Detection and application of neurochemical profile by multiple regional 1H-MRS in Parkinson's disease.
    Guan J, Rong Y, Wen Y, Wu H, Qin H, Zhang Q, Chen W.
    Brain Behav; 2017 Sep; 7(9):e00792. PubMed ID: 28948086
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Whole-brain proton MR spectroscopic imaging of mild-to-moderate traumatic brain injury and correlation with neuropsychological deficits.
    Govind V, Gold S, Kaliannan K, Saigal G, Falcone S, Arheart KL, Harris L, Jagid J, Maudsley AA.
    J Neurotrauma; 2010 Mar; 27(3):483-96. PubMed ID: 20201668
    [Abstract] [Full Text] [Related]

  • 6. Proton spectroscopic imaging of brain metabolites in basal ganglia of healthy older adults.
    Parikh J, Thrippleton MJ, Murray C, Armitage PA, Harris BA, Andrews PJ, Wardlaw JM, Starr JM, Deary IJ, Marshall I.
    MAGMA; 2015 Jun; 28(3):251-7. PubMed ID: 25312604
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease.
    Weiduschat N, Mao X, Beal MF, Nirenberg MJ, Shungu DC, Henchcliffe C.
    J Neuroimaging; 2015 Jun; 25(1):105-10. PubMed ID: 24325203
    [Abstract] [Full Text] [Related]

  • 8. Region-specific Cerebral Metabolic Alterations in Parkinson's Disease Patients With/without Mild Cognitive Impairment.
    Huang M, Yu H, Lyu X, Pu W, Yin J, Gao B.
    Neuroscience; 2024 Jul 23; 551():254-261. PubMed ID: 38848776
    [Abstract] [Full Text] [Related]

  • 9. Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy.
    Govind V, Sharma KR, Maudsley AA, Arheart KL, Saigal G, Sheriff S.
    PLoS One; 2012 Jul 23; 7(4):e35607. PubMed ID: 22539984
    [Abstract] [Full Text] [Related]

  • 10. Proton MR spectroscopic imaging of the striatum in Parkinson's disease.
    Cruz CJ, Aminoff MJ, Meyerhoff DJ, Graham SH, Weiner MW.
    Magn Reson Imaging; 1997 Jul 23; 15(6):619-24. PubMed ID: 9285801
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment.
    Nie K, Zhang Y, Huang B, Wang L, Zhao J, Huang Z, Gan R, Wang L.
    Parkinsonism Relat Disord; 2013 Mar 23; 19(3):329-34. PubMed ID: 23238068
    [Abstract] [Full Text] [Related]

  • 15. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Almuqbel M, Melzer TR, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Wood KL, Keenan RJ, Dalrymple-Alford JC, Anderson TJ.
    Parkinsonism Relat Disord; 2016 Jan 23; 22():54-61. PubMed ID: 26627939
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J, Zimny A, Knysz B, Małyszczak K, Kołtowska A, Szewczyk P, Gąsiorowski J, Furdal M, Sąsiadek MJ.
    J Hepatol; 2013 Oct 23; 59(4):651-7. PubMed ID: 23680314
    [Abstract] [Full Text] [Related]

  • 17. Temporal pole proton preoperative magnetic resonance spectroscopy in patients undergoing surgery for mesial temporal sclerosis.
    Fountas KN, Tsougos I, Gotsis ED, Giannakodimos S, Smith JR, Kapsalaki EZ.
    Neurosurg Focus; 2012 Mar 23; 32(3):E3. PubMed ID: 22380857
    [Abstract] [Full Text] [Related]

  • 18. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
    Mendes-Ribeiro JA, Soares R, Simões-Ribeiro F, Guimarães ML.
    J Neurol Neurosurg Psychiatry; 1998 Oct 23; 65(4):518-22. PubMed ID: 9771777
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Computation of brain metabolite ratios in single-voxel proton MR spectroscopy: comparison between semiautomatic and automatic software.
    Mazzoni LN, Belli G, Ginestroni A, Pratesi A, Agnoloni S, Diciotti S, Mascalchi M.
    Radiol Med; 2010 Feb 23; 115(1):125-32. PubMed ID: 19562268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.